tiprankstipranks
Advertisement
Advertisement
Imunon Expands At-The-Market Equity Offering Capacity
PremiumCompany AnnouncementsImunon Expands At-The-Market Equity Offering Capacity
1M ago
Imunon announces orderly retirement of chief scientific officer
Premium
Company Announcements
Imunon announces orderly retirement of chief scientific officer
3M ago
Imunon announces reorganization to eliminate headcount for Phase 3 trial
Premium
The Fly
Imunon announces reorganization to eliminate headcount for Phase 3 trial
3M ago
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices
PremiumCompany AnnouncementsImunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices
6M ago
IMUNON, Inc. Reports Q3 2025 Results and Progress
Premium
Company Announcements
IMUNON, Inc. Reports Q3 2025 Results and Progress
6M ago
Imunon, Inc. Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Imunon, Inc. Earnings Call Highlights Progress and Challenges
6M ago
Imunon to present Phase 3 OVATION 3 study of IMNN-001
PremiumThe FlyImunon to present Phase 3 OVATION 3 study of IMNN-001
6M ago
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
Premium
Company Announcements
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
6M ago
Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
Premium
Company Announcements
Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100